undefined

Hirsh Elhence

Internal medicine resident at the University of Colorado. He presented the hepatology case in this episode.

Top 3 podcasts with Hirsh Elhence

Ranked by the Snipd community
undefined
Aug 15, 2025 • 44min

Episode 413: Rafael Medina Hepatology Episode with Dr. Tapper – Driver or Bystander

Elliot Tapper is an Associate Professor in Gastroenterology and Hepatology at the University of Michigan, while Hirsh Elhence is an Internal Medicine resident at the University of Colorado with a keen interest in hepatology. They explore whether the liver is a driver of health issues or merely a bystander. Key topics include navigating liver transplant evaluations, distinguishing between acute liver injury and acute liver failure, and unraveling complex liver cases. Their engaging dialogue emphasizes patient-centered care and the importance of detailed medical assessment.
undefined
Sep 19, 2024 • 6min

391. Guidelines: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure – Question #35 with Dr. Mark Drazner

Dr. Mark Drazner, an advanced heart failure and transplant cardiologist, joins Dr. Hirsh Elhence, a resident in internal medicine, and Dr. Mark Belkin, a critical care cardiology expert. They delve into heart failure management, exploring a case study of a woman with improved ejection fraction, the significance of LVEF classifications, and the latest terminology such as 'heart failure in remission.' Genetic factors affecting treatment are also discussed, highlighting the complexities of individualized care for heart failure patients.
undefined
Aug 9, 2024 • 5min

385. Guidelines: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure – Question #34 with Dr. Mark Drazner

Dr. Mark Drazner, an advanced heart failure and transplant cardiologist, joins Dr. Hirsh Elhence, a medicine resident, and Dr. Mark Belkin from the University of Chicago. They explore the management of heart failure with a focus on device indications after myocardial infarction. Key discussions highlight the role of implantable cardioverter-defibrillators for sudden cardiac death prevention and the criteria for cardiac resynchronization therapy. They also navigate the complex decisions around life vests and ensure patient-centered approaches in heart failure management.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app